# Mbia Inc: financial statements, quarterly

MBI · NYSE · CIK 814585 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mbi.md) · [Financials](/companies/mbi/financials.md) · [Filings](/companies/mbi/filings.md) · [Insiders](/companies/mbi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mbi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.0](/filings/0000950170-24-123396.md) | [(31.0) d](/filings/0001193125-26-076834.md) | [13.0](/filings/0000950170-25-067046.md) | [(37.0)](/filings/0000950170-25-104115.md) | [29.0](/filings/0001193125-25-264782.md) | [37.0 d](/filings/0001193125-26-076834.md) | [14.0](/filings/0001193125-26-212078.md) | [23.0](/filings/0001193125-26-338136.md) | [15.0](/filings/0001193125-25-264782.md) | [28.0 d](/filings/0001193125-26-076834.md) | [24.0](/filings/0001193125-26-212078.md) | [27.0](/filings/0001193125-26-338136.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [53.0](/filings/0000950170-24-123396.md) | [53.0 d](/filings/0001193125-26-076834.md) | [52.0](/filings/0000950170-25-067046.md) | [53.0](/filings/0000950170-25-104115.md) | [53.0](/filings/0001193125-25-264782.md) | [50.0 d](/filings/0001193125-26-076834.md) | [50.0](/filings/0001193125-26-212078.md) | [48.0](/filings/0001193125-26-338136.md) | [50.0](/filings/0001193125-25-264782.md) | [48.0 d](/filings/0001193125-26-076834.md) | [47.0](/filings/0001193125-26-212078.md) | [48.0](/filings/0001193125-26-338136.md) |
| Income tax | $m | [0.0](/filings/0000950170-24-123396.md) | [0.0 d](/filings/0001193125-26-076834.md) | [0.0](/filings/0000950170-25-067046.md) | [0.0](/filings/0000950170-25-104115.md) | [0.0](/filings/0001193125-25-264782.md) | [0.0 d](/filings/0001193125-26-076834.md) | [0.0](/filings/0001193125-26-212078.md) | [0.0](/filings/0001193125-26-338136.md) | [0.0](/filings/0001193125-25-264782.md) | [0.0 d](/filings/0001193125-26-076834.md) | [0.0](/filings/0001193125-26-212078.md) | [0.0](/filings/0001193125-26-338136.md) |
| Net income | $m | [(185)](/filings/0000950170-24-123396.md) | [830 d](/filings/0001193125-26-076834.md) | [(86.0)](/filings/0000950170-25-067046.md) | [(254)](/filings/0000950170-25-104115.md) | [(56.0)](/filings/0001193125-25-264782.md) | [831 d](/filings/0001193125-26-076834.md) | [(62.0)](/filings/0001193125-26-212078.md) | [(56.0)](/filings/0000950170-25-104115.md) | [(8.0)](/filings/0001193125-25-264782.md) | [(51.0) d](/filings/0001193125-26-076834.md) | [(40.0)](/filings/0001193125-26-212078.md) | [(43.0)](/filings/0001193125-26-338136.md) |
| Diluted EPS | $ per share | [(3.94)](/filings/0000950170-24-123396.md) | not reported | [(1.84)](/filings/0000950170-25-067046.md) | [(5.34)](/filings/0000950170-25-104115.md) | [(1.18)](/filings/0001193125-25-264782.md) | not reported | [(1.28)](/filings/0001193125-26-212078.md) | [(1.12)](/filings/0001193125-26-338136.md) | [(0.17)](/filings/0001193125-25-264782.md) | not reported | [(0.80)](/filings/0001193125-26-212078.md) | [(0.91)](/filings/0001193125-26-338136.md) |
| Basic EPS | $ per share | [(3.94)](/filings/0000950170-24-123396.md) | not reported | [(1.84)](/filings/0000950170-25-067046.md) | [(5.34)](/filings/0000950170-25-104115.md) | [(1.18)](/filings/0001193125-25-264782.md) | not reported | [(1.28)](/filings/0001193125-26-212078.md) | [(1.12)](/filings/0001193125-26-338136.md) | [(0.17)](/filings/0001193125-25-264782.md) | not reported | [(0.80)](/filings/0001193125-26-212078.md) | [(0.91)](/filings/0001193125-26-338136.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,990](/filings/0000950170-23-058243.md) | [2,606](/filings/0001193125-26-076834.md) | [2,488](/filings/0000950170-25-067046.md) | [2,304](/filings/0000950170-25-104115.md) | [2,230](/filings/0001193125-25-264782.md) | [2,168](/filings/0001193125-26-076834.md) | [2,132](/filings/0001193125-26-212078.md) | [2,134](/filings/0001193125-26-338136.md) | [2,060](/filings/0001193125-25-264782.md) | [2,013](/filings/0001193125-26-338136.md) | [1,979](/filings/0001193125-26-212078.md) | [1,979](/filings/0001193125-26-338136.md) |
| Total liabilities | $m | [4,218](/filings/0000950170-23-058243.md) | [4,253](/filings/0000950170-25-029081.md) | [4,211](/filings/0000950170-24-057012.md) | [4,289](/filings/0000950170-24-091862.md) | [4,218](/filings/0000950170-24-123396.md) | [4,244](/filings/0001193125-26-076834.md) | [4,245](/filings/0000950170-25-067046.md) | [4,299](/filings/0000950170-25-104115.md) | [4,227](/filings/0001193125-25-264782.md) | [4,243](/filings/0001193125-26-338136.md) | [4,257](/filings/0001193125-26-212078.md) | [4,297](/filings/0001193125-26-338136.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(1,239)](/filings/0000950170-23-058243.md) | [(1,657)](/filings/0000950170-25-029081.md) | [(1,733)](/filings/0000950170-24-057012.md) | [(1,994)](/filings/0000950170-24-091862.md) | [(2,001)](/filings/0000950170-24-123396.md) | [(2,089)](/filings/0001193125-26-076834.md) | [(2,126)](/filings/0000950170-25-067046.md) | [(2,178)](/filings/0000950170-25-104115.md) | [(2,180)](/filings/0001193125-25-264782.md) | [(2,237)](/filings/0001193125-26-338136.md) | [(2,283)](/filings/0001193125-26-212078.md) | [(2,326)](/filings/0001193125-26-338136.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(115) d](/filings/0000950170-24-123396.md) | [(2.0) d](/filings/0001193125-26-076834.md) | [(30.0)](/filings/0000950170-25-067046.md) | [(10.0) d](/filings/0000950170-25-104115.md) | [(139) d](/filings/0001193125-25-264782.md) | [3.0 d](/filings/0001193125-26-076834.md) | [(43.0)](/filings/0001193125-26-212078.md) | [1.0 d](/filings/0001193125-26-338136.md) | [90.0 d](/filings/0001193125-25-264782.md) | [(10.0) d](/filings/0001193125-26-076834.md) | [(33.0)](/filings/0001193125-26-212078.md) | [(4.0) d](/filings/0001193125-26-338136.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [7.0 d](/filings/0000950170-24-123396.md) | [3.0 d](/filings/0001193125-26-076834.md) | [2.0](/filings/0000950170-25-067046.md) | [2.0 d](/filings/0000950170-25-104115.md) | [0.0 d](/filings/0001193125-25-264782.md) | [0.0 d](/filings/0001193125-26-076834.md) | [7.0](/filings/0001193125-26-212078.md) | [0.0 d](/filings/0001193125-26-338136.md) | [0.0 d](/filings/0001193125-25-264782.md) | [0.0 d](/filings/0001193125-26-076834.md) | [1.0](/filings/0001193125-26-212078.md) | [0.0 d](/filings/0001193125-26-338136.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.9](/filings/0000950170-23-058243.md) | [49.9](/filings/0000950170-24-057012.md) | [49.0](/filings/0000950170-24-091862.md) | [47.0](/filings/0000950170-24-123396.md) | [46.8](/filings/0000950170-25-067046.md) | [47.5](/filings/0000950170-25-104115.md) | [47.7](/filings/0001193125-25-264782.md) | [48.4](/filings/0001193125-26-212078.md) | [49.5](/filings/0001193125-26-338136.md) | [49.6](/filings/0001193125-25-264782.md) | [49.8](/filings/0001193125-26-212078.md) | [50.2](/filings/0001193125-26-338136.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,016,444 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-338136.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.